Pilot Feasibility Study of the Safety and Efficacy of Anakinra in Heart Failure With Preserved Ejection Fraction.

Trial Profile

Pilot Feasibility Study of the Safety and Efficacy of Anakinra in Heart Failure With Preserved Ejection Fraction.

Completed
Phase of Trial: Phase II

Latest Information Update: 08 Feb 2017

At a glance

  • Drugs Anakinra (Primary)
  • Indications Heart failure
  • Focus Therapeutic Use
  • Acronyms D-HART Pilot Study
  • Most Recent Events

    • 07 Jun 2017 Biomarkers information updated
    • 17 Nov 2013 Results presented at the 86th Annual Scientific Sessions of the American Heart Association.
    • 04 Oct 2013 Results published in the American Journal of Cardiology.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top